# US 2001/0024666 A1 · Composition for and method of reducing low density lipoprotein cholesterol concentration

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2001/0024666 A1
- Document ID: US20010024666A1
- Status: Published application
- Kind: A1
- Application number: 09/826,346
- Filed: 2001-04-04
- Published: 2001-09-27
- Earliest claimed: 1999-04-23
- Assignees: Protein Technologies International, Inc.
- Inventors: Doyle H. Waggle; Susan M. Potter; Edna C. Henley
- Web page: https://patentgrep.com/patent/US20010024666A1

## CPC

- A61K 36/48: Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A23L 33/11: Plant sterols or derivatives thereof, e.g. phytosterols
- A23L 33/185: Vegetable proteins
- A61K 31/78: of acrylic acid or derivatives thereof
- A61P 3/06: Antihyperlipidemics
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION

## Abstract

The present invention is a composition comprising a plant sterol and a soy protein material and/or and isoflavone selected from genistein, daidzein, glycitein, biochanin A, formononetin, and their naturally occurring glycosides, where the plant sterol comprises at least 0.49% of the composition, by weight. The present invention is also a method for decreasing the blood concentration of total and LDL cholesterol in a human in which a plant sterol and a soy protein material and/or an isoflavone are co-administered to the human, where the plant sterol comprises at least 0.49%, by weight, of the combined weight of the plant sterol and the soy protein material and/or the isoflavone. The present invention is also a method for preventing or minimizing the development of atherosclerosis in a human in which a plant sterol and a soy protein material and/or an isoflavone are co-administered to the human, where the plant sterol comprises at least 0.49%, by weight, of the combined weight of the plant sterol and the soy protein material and/or the isoflavone.

## Claims

### Claim 1

A composition, comprising:
a soy protein material containing at least 49% soy protein by dry weight of the soy protein material;
at least one isoflavone selected from the group consisting of genistein, daidzein, glycitein, biochanin A, formononetin, and their naturally occurring glycosides and glycoside conjugates; and
a plant sterol, where said plant sterol comprises at least 0.49% of said composition by weight.

### Claim 2 (depends on 1)

The composition of claim 1 wherein said soy protein material is a soy protein isolate.

### Claim 3 (depends on 1)

The composition of claim 1 wherein said soy protein material is selected from at least one of the group consisting of soy protein concentrate, soy flour, or soy grit.

### Claim 4 (depends on 1)

The composition of claim 1 wherein said plant sterol is at least one of β-sitosterol, campesterol, stigmasterol, sitostanol, or campestanol.

### Claim 5 (depends on 1)

The composition of claim 1 wherein said isoflavone comprises at least 0.0066% of said composition by weight.

### Claim 6 (depends on 1)

The composition of claim 1 further comprising an excipient, wherein said plant sterol, said soy protein material, said isoflavone, and said excipient are combined into a pharmaceutical or over-the-counter preparation.

### Claim 7 (depends on 6)

The composition of claim 6 wherein said pharmaceutical or over-the-counter preparation is a tablet, capsule, powder, suspension, or solution.

### Claim 8 (depends on 1)

The composition of claim 1 further comprising water, wherein said plant sterol, said soy protein material, said isoflavone, and said water are combined into an aqueous emulsion.

### Claim 9 (depends on 8)

The composition of claim 8 incorporated into a food material.

### Claim 10 (depends on 1)

The composition of claim 1 incorporated into a food material.

### Claim 11

A method for lowering blood concentration of total and low density lipoprotein cholesterol in a human, comprising:
co-administering a plant sterol, a soy protein material containing at least 49% soy protein by dry weight of the soy protein material, and at least one isoflavone selected from the group consisting of genistein, daidzein, glycitein, biochanin A, formononetin, and their naturally occurring glycosides and glycoside conjugates to said human to decrease the blood concentration of total and LDL cholesterol in said human, where said plant sterol comprises at least 0.49%, by weight, of the combined weight of the co-administered plant sterol, soy protein material, and isoflavone.

### Claim 12 (depends on 11)

The method of claim 11 wherein co-administration of said plant sterol, soy protein, and isoflavone is concurrent.

### Claim 13 (depends on 11)

The method of claim 11 wherein co-administration of said plant sterol, soy protein, and isoflavone is sequential.

### Claim 14 (depends on 11)

The method of claim 11 wherein said plant sterol is administered in a dose of from about 500 mg/day to about 50 g/day.

### Claim 15 (depends on 11)

The method of claim 11 wherein said soy protein material is administered in an amount of from about 5 g/day to about 100 g/day.

### Claim 16 (depends on 11)

The method of claim 11 wherein said isoflavone is administered in an amount of from about 10 mg/day to about 1000 mg/day.

### Claim 17 (depends on 11)

The method of claim 11 wherein said plant sterol is at least one of β-sitosterol, campesterol, stigmasterol, sitostanol, or campestanol.

### Claim 18 (depends on 11)

The method of claim 11 wherein said soy protein material is selected from at least one of a soy protein concentrate, a soy protein isolate, soy flour, and soy grit.

### Claim 19 (depends on 11)

The method of claim 11 wherein said plant sterol, said soy protein material, and said isoflavone are administered in a food.

### Claim 20 (depends on 11)

The method of claim 11 wherein said plant sterol, said soy protein material, and said isoflavone are administered in a pharmaceutical or over-the counter preparation.

### Claim 21 (depends on 20)

The method of claim 20 wherein said pharmaceutical or over-the-counter preparation is a tablet, capsule, powder, suspension, or solution.

### Claim 22

A method for preventing or minimizing the development of atherosclerosis, comprising:
co-administering a plant sterol, a soy protein material containing at least 49% soy protein by dry weight of the soy protein material, and an isoflavone selected from the group consisting of genistein, daidzein, glycitein, biochanin A, formononetin, and their naturally occurring glycosides and glycoside conjugates to said human to prevent or minimize the development of atherosclerosis, where said plant sterol comprises at least 0.49%, by weight, of the combined weight of the co-administered plant sterol, soy protein material, and isoflavone.

### Claim 23 (depends on 22)

The method of claim 22 wherein co-administration of said plant sterol, soy protein, and isoflavone is concurrent.

### Claim 24 (depends on 22)

The method of claim 22 wherein co-administration of said plant sterol, soy protein, and isoflavone is sequential.

### Claim 25 (depends on 22)

The method of claim 22 wherein said plant sterol is administered in a dose of from about 500 mg/day to about 50 g/day.

### Claim 26 (depends on 22)

The method of claim 22 wherein said soy protein material is administered in an amount of from about 5 g/day to about 100 g/day.

### Claim 27 (depends on 22)

The method of claim 22 wherein said isoflavone is administered in an amount of from about 10 mg/day to about 1000 mg/day.

### Claim 28 (depends on 22)

The method of claim 22 wherein said plant sterol is at least one of β-sitosterol, campesterol, stigmasterol, sitostanol, or campestanol.

### Claim 29 (depends on 22)

The method of claim 22 wherein said soy protein material is selected from at least one of a soy protein concentrate, a soy protein isolate, soy flour, or soy grit.

### Claim 30 (depends on 22)

The method of claim 22 wherein said plant sterol, said soy protein material, and said isoflavone are administered in a food.

### Claim 31 (depends on 22)

The method of claim 22 wherein said plant sterol, said soy protein material, and said isoflavone are administered in a pharmaceutical or over-the-counter preparation.

### Claim 32 (depends on 31)

The method of claim 31 wherein said pharmaceutical or over-the-counter preparation is a tablet, capsule, powder, suspension, or solution.

### Claim 33

A composition, comprising:
a soy protein material containing at least 49% soy protein by dry weight of the soy protein material; and
a plant sterol, where said plant sterol comprises at least 0.49% of said composition by weight.

### Claim 34 (depends on 33)

The composition of claim 33 wherein said soy protein material is a soy protein isolate.

### Claim 35 (depends on 33)

The composition of claim 33 wherein said soy protein material is selected from at least one of a soy protein concentrate, soy flour, or soy grit.

### Claim 36 (depends on 33)

The composition of claim 33 wherein said plant sterol is at least one of β-sitosterol, campesterol, stigmasterol, sitostanol, or campestanol.

### Claim 37 (depends on 33)

The composition of claim 33 further comprising an excipient, wherein said plant sterol, said soy protein material, and said excipient are combined in a pharmaceutical or over-the-counter preparation.

### Claim 38 (depends on 37)

The composition of claim 37 wherein said pharmaceutical or over-the-counter preparation is a tablet, capsule, suspension, or solution.

### Claim 39 (depends on 33)

The composition of claim 33 further comprising water, wherein said plant sterol, said soy protein material, and said water are mixed into an aqueous emulsion.

### Claim 40 (depends on 39)

The composition of claim 39 incorporated into a food material.

### Claim 41 (depends on 33)

The composition of claim 33 incorporated into a food material.

### Claim 42

A method for lowering blood concentration of total and low density lipoprotein cholesterol in a human, comprising:
co-administering a plant sterol and a soy protein material containing at least 49% soy protein by dry weight of the soy protein material to a human to decrease the blood concentration of total and LDL cholesterol in said human, where said plant sterol comprises at least 0.49%, by weight, of the combined weight of the co-administered plant sterol and soy protein material.

### Claim 43 (depends on 42)

The method of claim 42 wherein co-administration of said plant sterol and said soy protein is concurrent.

### Claim 44 (depends on 42)

The method of claim 42 wherein co-administration of said plant sterol and said soy protein material is sequential.

### Claim 45 (depends on 42)

The method of claim 42 wherein said plant sterol is administered in a dose of from about 500 mg/day to about 50 g/day.

### Claim 46 (depends on 42)

The method of claim 42 wherein said soy protein material is administered in an amount of from about 5 g/day to about 100 g/day.

### Claim 47 (depends on 42)

The method of claim 42 wherein said plant sterol is at least one of β-sitosterol, campesterol, stigmasterol, sitostanol, or campestanol.

### Claim 48 (depends on 42)

The method of claim 42 wherein said soy protein material is at least one of a soy protein concentrate, a soy protein isolate, soy flour, and soy grit.

### Claim 49 (depends on 42)

The method of claim 42 wherein said plant sterol and said soy protein material are administered in a food.

### Claim 50 (depends on 42)

The method of claim 42 wherein said plant sterol and said soy protein material are administered in a pharmaceutical or over-the-counter preparation.

### Claim 51 (depends on 50)

The method of claim 50 wherein said pharmaceutical or over-the-counter preparation is a tablet, capsule, powder, suspension, or solution.

### Claim 52

A method for preventing or minimizing the development of atherosclerosis, comprising,
co-administering a plant sterol and a soy protein material containing at least 49% soy protein by dry weight of the soy protein material to said human to prevent or minimize the development of atherosclerosis, where said plant sterol comprises at least 0.49%, by weight, of the combined weight of the co-administered plant sterol and soy protein material.

### Claim 53 (depends on 52)

The method of claim 52 wherein co-administration of said plant sterol and said soy protein is concurrent.

### Claim 54 (depends on 52)

The method of claim 52 wherein co-administration of said plant sterol and said soy protein material is sequential.

### Claim 55 (depends on 52)

The method of claim 52 wherein said plant sterol is administered in a dose of from about 500 mg/day to about 50 g/day.

### Claim 56 (depends on 52)

The method of claim 52 wherein said soy protein material is administered in an amount of from about 5 g/day to about 100 g/day.

### Claim 57 (depends on 52)

The method of claim 52 wherein said plant sterol is at least one of β-sitosterol, campesterol, stigmasterol, sitostanol, or campestanol.

### Claim 58 (depends on 52)

The method of claim 52 wherein said soy protein material is at least one of a soy protein concentrate, a soy protein isolate, soy flour, and soy grit.

### Claim 59 (depends on 52)

The method of claim 52 wherein said plant sterol and said soy protein material are administered in a food.

### Claim 60 (depends on 52)

The method of claim 52 wherein said plant sterol and said soy protein material are administered in a pharmaceutical or over-the-counter preparation.

### Claim 61 (depends on 60)

The method of claim 60 wherein said pharmaceutical or over-the-counter preparation is a tablet, capsule, powder, suspension, or solution.

### Claim 62

A composition, comprising:
at least one isoflavone selected from the group consisting of genistein, daidzein, glycitein, biochanin A, formononetin, and their naturally occurring glycosides and glycoside conjugates; and
a plant sterol, where said plant sterol comprises at least 0.49% of said composition by weight.

### Claim 63 (depends on 62)

The composition of claim 62 wherein said plant sterol is at least one of β-sitosterol, campesterol, stigmasterol, sitostanol, or campestanol.

### Claim 64 (depends on 62)

The composition of claim 62 wherein said isoflavone comprises at least 0.0066% of said composition by weight.

### Claim 65 (depends on 62)

The composition of claim 62 further comprising an excipient, where said plant sterol, said isoflavone, and said excipient are combined into a pharmaceutical or over-the-counter preparation.

### Claim 66 (depends on 65)

The composition of claim 65 wherein said pharmaceutical or over-the-counter preparation is a tablet, capsule, powder, suspension, or solution.

### Claim 67 (depends on 62)

The composition of claim 62 further comprising water, wherein said plant sterol and said isoflavone are combined into an aqueous emulsion.

### Claim 68 (depends on 67)

The composition of claim 67 incorporated into a food material.

### Claim 69 (depends on 62)

The composition of claim 62 incorporated into a food material.

### Claim 70

A method for lowering blood concentration of total and low density lipoprotein cholesterol in a human, comprising:
co-administering a plant sterol and an isoflavone selected from the group consisting of genistein, daidzein, glycitein, biochanin A, formononetin, and their naturally occurring glycosides and glycoside conjugates to said human to decrease the blood concentration of total and LDL cholesterol in said human, where said plant sterol comprises at least 0.49%, by weight, of the combined weight of the co-administered plant sterol and isoflavone.

### Claim 71 (depends on 70)

The method of claim 70 wherein co-administration of said plant sterol and said isoflavone is concurrent.

### Claim 72 (depends on 70)

The method of claim 70 wherein co-administration of said plant sterol and said isoflavone is sequential.

### Claim 73 (depends on 70)

The method of claim 70 wherein said plant sterol is administered in a dose of from about 500 mg/day to about 50 g/day.

### Claim 74 (depends on 70)

The method of claim 70 wherein said isoflavone is administered in an amount of from about 10 mg/day to about 1000 mg/day.

### Claim 75 (depends on 70)

The method of claim 70 wherein said plant sterol is at least one of β-sitosterol, campesterol, stigmasterol, sitostanol, or campestanol.

### Claim 76 (depends on 70)

The method of claim 70 wherein said plant sterol and said isoflavone are administered in a food.

### Claim 77 (depends on 70)

The method of claim 70 wherein said plant sterol and said isoflavone are administered in a pharmaceutical or over-the-counter preparation.

### Claim 78

A method for preventing or minimizing the development of atherosclerosis, comprising co-administering a plant sterol and an isoflavone selected from the group consisting of genistein, daidzein, glycitein, biochanin A, formononetin, and their naturally occurring glycosides and glycoside conjugates to said human to prevent or minimize the development of atherosclerosis, where said plant sterol comprises at least 0.49%, by weight, of the combined weight of the co-administered plant sterol and isoflavone.

### Claim 79 (depends on 78)

The method of claim 78 wherein co-administration of said plant sterol and said isoflavone is concurrent.

### Claim 80 (depends on 78)

The method of claim 78 wherein co-administration of said plant sterol and said isoflavone is sequential.

### Claim 81 (depends on 78)

The method of claim 78 wherein said plant sterol is administered in a dose of from about 500 mg/day to about 50 g/day.

### Claim 82 (depends on 78)

The method of claim 78 wherein said isoflavone is administered in an amount of from about 10 mg/day to about 1000 mg/day.

### Claim 83 (depends on 78)

The method of claim 78 wherein said plant sterol is at least one of β-sitosterol, campesterol, stigmasterol, sitostanol, or campestanol.

### Claim 84 (depends on 78)

The method of claim 78 wherein said plant sterol and said isoflavone are administered in a food.

### Claim 85 (depends on 78)

The method of claim 78 wherein said plant sterol and said isoflavone are administered in a pharmaceutical or over-the-counter preparation.

### Claim 86 (depends on 85)

The method of claim 85 wherein said pharmaceutical or over-the-counter preparation is a tablet, capsule, powder, suspension, or solution.

### Claim 87

A composition, comprising:
a soy hypocotyl material; and
a plant sterol, where said plant sterol comprises at least 0.49% of said composition by weight.

### Claim 88 (depends on 87)

The composition of claim 87 further comprising at least one isoflavone selected from genistein, daidzein, glycitein biochanin A, formononetin, and their naturally occuring glycosides and glycoside conjugates.

### Claim 89 (depends on 87)

The composition of claim 87 wherein said plant sterol is at least one of β-sitosterol, campesterol, stigmasterol, sitostanol, or campestanol.

### Claim 90

A method for lowering blood concentration of total and low density lipoprotein cholesterol in a human comprising:
co-administering a plant sterol and a soy hypocotyl material to a human to decrease the blood concentration of total and LDL cholesterol in said human, where said plant sterol comprises at least 0.49%, by weight, of the combined weight of the co-administered plant sterol and soy hypocotyl material.

### Claim 91 (depends on 90)

The method of claim 90, further comprising administering an isoflavone selected from the group consisting of genistein, daidzein, glycitein, biochanin A, formononetin, and their naturally occuring glycosides and glycoside conjugates.

### Claim 92 (depends on 91)

The method of claim 91 wherein said plant sterol, said soy hypocotyl material, and said isoflavone are further administered to prevent or minimize the development of atheroscelerosis.
